RHJA
RVNC

Rice Hall James & Associates’s Revance Therapeutics, Inc. RVNC Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-678,541
Closed -$2.06M 257
2024
Q4
$2.06M Sell
678,541
-51,649
-7% -$157K 0.11% 174
2024
Q3
$3.79M Buy
730,190
+18,118
+3% +$94K 0.21% 111
2024
Q2
$1.83M Sell
712,072
-34,067
-5% -$87.6K 0.11% 169
2024
Q1
$3.67M Sell
746,139
-11,909
-2% -$58.6K 0.21% 101
2023
Q4
$6.66M Buy
758,048
+74,111
+11% +$651K 0.39% 65
2023
Q3
$7.84M Buy
683,937
+131,442
+24% +$1.51M 0.5% 53
2023
Q2
$14M Sell
552,495
-256,681
-32% -$6.5M 0.79% 37
2023
Q1
$26.1M Sell
809,176
-66,320
-8% -$2.14M 1.48% 14
2022
Q4
$16.2M Sell
875,496
-21,258
-2% -$392K 0.93% 34
2022
Q3
$24.2M Sell
896,754
-188,586
-17% -$5.09M 1.4% 16
2022
Q2
$15M Sell
1,085,340
-26,985
-2% -$373K 0.73% 42
2022
Q1
$21.7M Sell
1,112,325
-1,620
-0.1% -$31.6K 0.86% 37
2021
Q4
$18.2M Buy
1,113,945
+194,185
+21% +$3.17M 0.65% 45
2021
Q3
$25.6M Sell
919,760
-6,130
-0.7% -$171K 0.95% 33
2021
Q2
$27.4M Sell
925,890
-180,657
-16% -$5.35M 0.98% 34
2021
Q1
$30.9M Sell
1,106,547
-14,605
-1% -$408K 1.01% 33
2020
Q4
$31.8M Sell
1,121,152
-8,864
-0.8% -$251K 1.12% 32
2020
Q3
$28.4M Buy
1,130,016
+96,737
+9% +$2.43M 1.14% 30
2020
Q2
$25.2M Buy
1,033,279
+2,998
+0.3% +$73.2K 1.08% 27
2020
Q1
$15.2M Sell
1,030,281
-35,847
-3% -$531K 0.85% 35
2019
Q4
$17.3M Sell
1,066,128
-12,569
-1% -$204K 0.59% 67
2019
Q3
$14M Buy
1,078,697
+195,928
+22% +$2.55M 0.5% 81
2019
Q2
$11.5M Buy
882,769
+765,701
+654% +$9.93M 0.38% 97
2019
Q1
$1.85M Buy
117,068
+83,875
+253% +$1.32M 0.06% 203
2018
Q4
$668K Buy
33,193
+8,821
+36% +$178K 0.02% 261
2018
Q3
$606K Buy
+24,372
New +$606K 0.02% 265